Not a good buy right now: price broke below key support (S1 3.586) and momentum is still deteriorating.
No Intellectia edge today (AI Stock Picker: no signal; SwingMax: no recent signal), so there’s no strong tactical reason to step in while trend is weak.
With an impatient profile and no need to wait for an “ideal” entry, the better decision is to avoid/exit rather than try to catch an oversold bounce.
Technical Analysis
Trend/Momentum: MACD histogram is negative (-0.122) and negatively expanding, signaling accelerating bearish momentum.
RSI: RSI_6 at ~25 indicates oversold conditions (despite the label provided), which can allow short bounces—but oversold alone is not a buy signal while MACD worsens.
Moving averages: converging MAs suggest uncertainty/transition, but current price action is still to the downside.
Levels: Pivot 4.113 is well above current 3.45 (post-market), implying the stock is trading in a weak zone. Support levels: S1 3.586 already lost; next support S2 3.261. Resistances: R1 4.639 and R2 4.964 are far overhead.
Pattern-based odds provided: only a 40% chance of a small next-day move; even the month projection is modest relative to the immediate downside trend.
Potential technical bounce setup: RSI_6 near oversold can sometimes trigger short-lived rebounds.
Broader market tailwind is mild (S&P 500 +0.2% in the session), which can marginally help risk assets.
Neutral/Negative Catalysts
with next support not far (S2 3.261), increasing risk of continued downside.
Financial Performance
Latest quarter provided: 2025/Q3.
Revenue: reported as 0 (0.00% YoY), implying no demonstrated top-line growth in the snapshot.
Profitability: Net income dropped to 12,088,469 (down -423.12% YoY), showing major deterioration versus the prior year period.
EPS: 0.48 (down -233.33% YoY), also sharply worse YoY.
Overall: the snapshot points to unstable/weak fundamentals and does not support a confident near-term “buy now” thesis.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target updates were provided, suggesting limited or no actionable Wall Street coverage in the dataset.
Wall Street pros/cons view (based on available data):
Pros: none clearly evidenced (no upgrades/targets, no stated catalysts).
Cons: absent analyst support combined with weak technicals and deteriorating YoY profitability increases the case to avoid rather than buy.
Wall Street analysts forecast GDC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GDC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast GDC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GDC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
